Gamma-Glutamyl Transpeptidase (GGT): A Potential Diagnostic Marker for Helicobacter Pylori Infections
1 other identifier
observational
100
1 country
1
Brief Summary
The investigators hypothesis: Presence of anti-GGT (antibody against GGT) indicates H. pylori infection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2014
CompletedFirst Submitted
Initial submission to the registry
April 24, 2014
CompletedFirst Posted
Study publicly available on registry
April 28, 2014
CompletedApril 28, 2014
April 1, 2014
10 months
April 24, 2014
April 25, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Stool anti-GGT for the diagnosis of Helicobactor Pylori Infection
1-5g of stool samples will also be collected from patients recruited to this study, in a preliminary investigation to determine the sensitivity and specificity of a stool H.pylori antigen test. Rapid urese test is the gold standard.
1 month after stool samples collected
Study Arms (1)
Helicobactor Pylori Infection
Comparison on the presence/absence of GGT antigen in the stool will be compared between H. pylori-positive and H. pylori-negative subjects. Rapid urease test result from the respective patients will be used as the golden standard. Should the GGT antigen in stool samples show promise in distinguishing between H. pylori-infected and uninfected individuals, sensitivity and specificity of the stool antigen test can then be established.
Eligibility Criteria
A total of 100 patients seen in Gastro clinic will be recruited for this study. Patient should 21 years and above and agreeable for study. Patient should not have been treated for H. pylori prior to stool collection.
You may qualify if:
- The subject is greater than 21 years of age.
- The subject must have personally signed and dated the patient informed consent form indicating that he/she has been informed of all pertinent aspects of the study.
- The subject must be willing and able to comply with scheduled visits and other study procedures.
You may not qualify if:
- Subjects who have been taking antibiotics over the past 1 month will be excluded from study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nuhs Umc/Udc
Singapore, Singapore, Singapore
Related Publications (1)
Gong M, Ling SS, Lui SY, Yeoh KG, Ho B. Helicobacter pylori gamma-glutamyl transpeptidase is a pathogenic factor in the development of peptic ulcer disease. Gastroenterology. 2010 Aug;139(2):564-73. doi: 10.1053/j.gastro.2010.03.050. Epub 2010 Mar 27.
PMID: 20347814BACKGROUND
Biospecimen
Stool samples(solid/semi-solid) between 1-5 g will be collected and tested using ELISA for the presence of the H. pylori GGT antigen using monoclonal antibodies against GGT.
Study Officials
- PRINCIPAL INVESTIGATOR
Lee Guan Lim
NUHS
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof Yeoh Khay Guan
Study Record Dates
First Submitted
April 24, 2014
First Posted
April 28, 2014
Study Start
May 1, 2013
Primary Completion
March 1, 2014
Last Updated
April 28, 2014
Record last verified: 2014-04